Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, Arizona, USA.
Curr Opin Support Palliat Care. 2014 Jun;8(2):143-51. doi: 10.1097/SPC.0000000000000055.
Chronic pain is an important public health problem that negatively impacts quality of life of affected individuals and exacts an enormous socio-economic cost. Currently available therapeutics provide inadequate management of pain in many patients. Acute pain states generally resolve in most patients. However, for reasons that are poorly understood, in some individuals, acute pain can transform to a chronic state. Our understanding of the risk factors that underlie the development of chronic pain is limited. Recent studies have suggested an important contribution of dysfunction in descending pain modulatory circuits to pain 'chronification'. Human studies provide insights into possible endogenous and exogenous factors that may promote the conversion of pain into a chronic condition.
Descending pain modulatory systems have been studied and characterized in animal models. Human brain imaging techniques, deep brain stimulation and the mechanisms of action of drugs that are effective in the treatment of pain confirm the clinical relevance of top-down pain modulatory circuits. Growing evidence supports the concept that chronic pain is associated with a dysregulation in descending pain modulation. Disruption of the balance of descending modulatory circuits to favour facilitation may promote and maintain chronic pain. Recent findings suggest that diminished descending inhibition is likely to be an important element in determining whether pain may become chronic. This view is consistent with the clinical success of drugs that enhance spinal noradrenergic activity, such as serotonin/norepinephrine reuptake inhibitors (SNRIs), in the treatment of chronic pain states. Consistent with this concept, a robust descending inhibitory system may be normally engaged to protect against the development of chronic pain. Imaging studies show that higher cortical and subcortical centres that govern emotional, motivational and cognitive processes communicate directly with descending pain modulatory circuits providing a mechanistic basis to explain how exogenous factors can influence the expression of chronic pain in a susceptible individual.
Preclinical studies coupled with clinical pharmacologic and neuroimaging investigations have advanced our understanding of brain circuits that modulate pain. Descending pain facilitatory and inhibitory circuits arising ultimately in the brainstem provide mechanisms that can be engaged to promote or protect against pain 'chronification'. These systems interact with higher centres, thus providing a means through which exogenous factors can influence the risk of pain chronification. A greater understanding of the role of descending pain modulation can lead to novel therapeutic directions aimed at normalizing aberrant processes that can lead to chronic pain.
慢性疼痛是一个重要的公共健康问题,它会降低疼痛患者的生活质量,并造成巨大的社会经济成本。目前的治疗方法并不能充分缓解许多患者的疼痛。大多数急性疼痛患者的疼痛会自然缓解。然而,由于原因尚不清楚,在一些个体中,急性疼痛会转变为慢性状态。我们对导致慢性疼痛发展的危险因素的了解是有限的。最近的研究表明,下行疼痛调节回路的功能障碍对疼痛的“慢性化”有重要贡献。人体研究为可能促进疼痛转变为慢性疾病的内源性和外源性因素提供了一些见解。
下行疼痛调节系统在动物模型中已被研究和描述。人类脑成像技术、深部脑刺激和治疗疼痛有效的药物的作用机制证实了自上而下的疼痛调节回路的临床相关性。越来越多的证据支持这样一种观点,即慢性疼痛与下行疼痛调节失调有关。下行调节回路失衡,促进易化可能会促进和维持慢性疼痛。最近的研究结果表明,下行抑制的减少很可能是决定疼痛是否会变为慢性的一个重要因素。这一观点与增强脊髓去甲肾上腺素能活性的药物(如 5-羟色胺/去甲肾上腺素再摄取抑制剂(SNRIs))在治疗慢性疼痛状态中的临床疗效一致。与这一概念一致的是,一个强大的下行抑制系统可能会被正常激活,以防止慢性疼痛的发生。影像学研究表明,负责情绪、动机和认知过程的皮质和皮质下高级中枢与下行疼痛调节回路直接沟通,为解释外源性因素如何影响易感性个体的慢性疼痛表达提供了一种机制基础。
临床前研究结合临床药理学和神经影像学研究,提高了我们对调节疼痛的大脑回路的理解。最终源自脑干的下行疼痛促进和抑制回路为促进或保护疼痛“慢性化”提供了机制。这些系统与高级中枢相互作用,从而提供了一种途径,使外源性因素可以影响疼痛慢性化的风险。对下行疼痛调节作用的进一步了解可以为旨在使导致慢性疼痛的异常过程正常化的新的治疗方向提供指导。